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 Background: Pleural effusions represent a common complication after liver transplantation (LT) and chest drain (CD) place-
ment is frequently necessary.
 Material/Methods: In this retrospective cohort study, adult LT recipients between 2009 and 2016 were analyzed for pleural effu-
sion formation and its treatment within the first 10 postoperative days. The aim of the study was to compare 
different settings of CD placement with regard to intervention-related complications.
 Results: Overall, 597 patients met the inclusion criteria, of which 361 patients (60.5%) received at least 1 CD with-
in the study period. Patients with a MELD >25 were more frequently affected (75.7% versus 56.0%, P<0.001). 
Typically, CDs were placed in the intensive care unit (ICU) (66.8%) or in the operating room (14.1% during LT, 
11.5% in the context of reoperations). In total, 97.0% of the patients received a right-sided CD, presumably 
caused by local irritations. Approximately one-third (35.4%) of ICU-patients required pre-interventional opti-
mization of coagulation. Of the 361 patients receiving a CD, 15 patients (4.2%) suffered a post-interventional 
hemorrhage and 6 patients (1.4%) had a pneumothorax requiring further treatment. Less complications were 
observed when the CD was performed in the operating room compared to the ICU: 1 out 127 patients (0.8%) 
versus 20 out of 332 patients (6.0%); P=0.016.
 Conclusions: CD placement occurring in the operating room was associated with fewer complications in contrast to placement 
occurring in the ICU. Planned CD placement in the course of surgery might be favorable in high-risk patients.
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Background
Liver transplantation (LT) remains the only curative therapy 
for end-stage liver disease; LT was first performed more than 
50 years ago. Due to increasing clinical experience, as well as 
improvements in immunosuppression, survival rates have im-
proved in the intervening years [1,2]. In order to further improve 
the prognosis of liver transplant recipients, the management 
of postoperative complications has gained priority, considering 
that the rate of postoperative complications remains high [3].
The most common postoperative pulmonary complication fol-
lowing LT is a pleural effusion, with a reported incidence be-
tween 32% and 47% [4], and an association with a signifi-
cantly decreased short-term survival [5]. Effusions are most 
commonly identified unilaterally on the right side, are occa-
sionally bilateral and only rarely left-sided in isolation [5–7]. 
The necessity of chest drain (CD) placement varies between 
22.0% and 52.0% among these patients [5,6,8]. Amongst oth-
ers, the improvement of oxygenation [9,10] and pneumonia 
prophylaxis [11,12] are the fundamental intentions of treating 
pleural effusions. However, the benefits of this intervention 
must be weighed against possible complications of CD inser-
tion. Predominant problems after CD are pneumothorax and 
hemorrhage. Varying incidences have been reported, mostly 
for thoracentesis only, without tube insertion. Pneumothoraxes 
are reported in 0% to 3% of patients and are associated with 
higher costs and longer hospital stays [13–15]. A study an-
alyzing cirrhotic patients only – and therefore emphasizing 
a high-risk population – reported an incidence of 8.4% for 
pneumothorax after therapeutic thoracentesis in this popula-
tion [16]. Hemorrhagic complication rates range from 0% to 
2% [13]. Although the majority of recent studies in general 
populations do not recommend optimizing coagulation prior 
to pleural drainage placement, current guidelines recommend 
that non-urgent CD insertion should be avoided if the inter-
national normalization ratio (INR) is >1.5 [17,18]. In addition, 
in clinical practice expensive fresh frozen plasma and platelet 
concentrates are frequently administered to patients at high-
er risk of bleeding when interventions are required.
Although pleural effusion is a well-documented complication 
in the early phase following LT, data regarding the frequency 
of interventions and incidence of post-interventional compli-
cations remain scarce.
Thus, the aim of this study was to investigate the incidence of 
post-LT pleural effusions requiring drainage and to analyze the 
post-interventional complications in a high-volume transplant 
center to help inform future improvements in the manage-
ment of one of the most common complications following LT.
Material and Methods
Study design
This retrospective cohort study was conducted at the trans-
plantation center of the Charité University Hospital, Berlin, 
Germany. Patients receiving single liver or combined (multiv-
isceral or liver-kidney) transplantation between January 2009 
and December 2016 were included. Donor organs were de-
rived from deceased (full size and split grafts) as well as liv-
ing donors. The observation period ended at postoperative day 
10, as the focus of this study was on the early postoperative 
phase. If patients required retransplantation during the ini-
tial 10 days, this was accounted as a reoperation and the ob-
servation period ended at postoperative day 10 after retrans-
plantation. If patients required a retransplantation after the 
initial 10 days, this was treated as a separate case. Patients 
under the age of 18 years old were excluded, as were recip-
ients receiving combined liver-lung and/or liver-heart trans-
plantation, due to the routine necessity of chest drains follow-
ing intrathoracic surgery.
Definitions
Each patient received a chest x-ray directly prior to LT as part 
of the routine preparation at our center, which was the base-
line for this study. In the postoperative phase experienced sur-
geons and/or intensive care specialists on our specialized LT 
intensive care unit (ICU) indicated the necessity for CD place-
ment using thoracic ultrasound. There is currently no published 
guideline for stating the precise indications for CD in pleural 
effusion (e.g., specific volume of the effusion), especially not 
in this group of postoperative patients. Therefore, the indica-
tion was determined using clinical experience and depending 
on respiratory limitations, which corresponds with the rec-
ommendations of the Spanish Society for Pulmonology and 
Thoracic Surgery [17,19,20]. Different types of CDs were used: 
Pleuracan© (B. Braun Melsungen AG, Melsungen, Germany) or 
Thal-Quick Chest Tube Set from Cook Medical© (COOK MEDICAL 
LLC, Bloomington, IN, USA) via needle puncture, surgical suc-
tion drainage (Bülau drain) and thoracentesis without tube in-
sertion. The cutoff values for correction of bleeding risks were 
thrombocytes <50 000/µL and partial thromboplastin time >50 
seconds. In line with the guidelines for pneumonia, published 
by the Centers for Disease Control and Prevention, pneumo-
nia was defined as a new lung infiltrate plus leukocytosis or 
leukopenia and/or new onset of fever plus clinical evidence 
for pulmonary infection and/or a positive sputum culture [21].
Data collection
For data collection, electronic records of all patients who met 
the study criteria were used. This included ICU records, surgical 
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records, and radiological reports. Donor, recipient, and trans-
plantation characteristics were included to identify risk fac-
tors for pleural effusions. The primary endpoint of the study 
was the rate of required interventions due to pleural effusions 
during surgery or within 10 days following LT. Secondary out-
come measurements included the number of administered 
blood products for pre-interventional correction of bleeding 
risks, post-interventional complications, short-term patient 
survival, and the development of pneumonia.
Statistical analyses
Categorical data are presented as frequencies and percent-
ages and were compared using Pearson chi-squared tests. 
Continuous data are presented as either mean and standard 
deviation and was compared by independent 2 sample t-tests 
if parametric or as median and interquartile range and com-
pared by Mann-Whitney U tests if non-parametric. Logistic 
regression was carried out to identify risk factors for neces-
sitating thoracic drainage. Variables significant in univariate 
analysis were then studied in multivariate regression models 
using both forward and backward procedures with a signifi-
cance level of 0.05 for model entry and 0.10 for exclusion. For 
all variables considered for multivariable regression missing 
data was maximum 3.7% and therefore no procedures to im-
pute missing data were used. All statistical analyses were car-
ried out using IBM SPSS Statistics (IBM Corporation, Armonk, 
NY, USA, version 24) and a P-value of <0.05 was considered sig-
nificant. The study was approved by the local ethic commission 
(Charité’s Ethics Committee and approval number EA1/369/16).
Results
During the study period, 688 LTs were performed, of which 597 
patients fulfilled all the inclusion criteria; 65 patients were ex-
cluded because they were pediatric recipients and 3 patients 
received combined liver-lung transplantation. There were 23 
retransplantations performed within the first 10 days follow-
ing LT, which were, therefore, not categorized as separated 
cases (Figure 1).
Of these 597 patients, 361 patients (60.5%) received at least 1 
CD within the first 10 days after LT, during LT, or already had a 
CD prior to LT, with a total amount of 497 drainages. Patients 
who received a CD had a significantly lower body mass index 
(BMI) (26.2 versus 28.0; P<0.001) and a higher Model for End-
stage Liver Disease (MELD) score [22] preoperatively (P<0.001). 
In a high-risk patient cohort with a laboratory MELD > 25 prior 
to LT a total of 119 patients (75.7%) required CD compared to 
232 patients (56.0%) with a pre-transplant laboratory MELD 
£25 (P<0.001) (Table 1).
Calculated mean laboratory MELD score was 17.7 in the group 
of patients without pleural drainage and 22.0 in the group of 
patients with pleural drainage (P<0.001; median laboratory 
MELD 16 versus 22, P<0.001). Mean match MELD score (used 
for allocation by Eurotransplant) which includes MELD score 
exceptions (e.g., for patients with a diagnosis of hepatocellular 
carcinoma) was 23.8 for patients without chest drain and 26.9 
for patients with chest drain (P<0.001; median match MELD 
24 versus 28, P<0.001). Furthermore, existing survival-out-
come scores like balance of risk score (BAR) [23] and D-MELD 
score [24] were significantly elevated in the drainage-requir-
ing cohort (P<0.001 and P=0.002). Patients dependent on life 
support prior to LT – defined as dialysis (P=0.009), mechani-
cal ventilation (P<0.001) and catecholamine therapy (P<0.001) 
– were prone to receive a CD. Regarding intraoperative risk fac-
tors these patients received a greater number of packed red 
blood cells and fresh frozen plasma (both P<0.001), underwent 
multi-organ transplantation more often and operation time was 
longer (P=0.001). Concerning donor characteristics, donors of 
patients who received a CD were younger and had a lower BMI 
(P=0.048 and P<0.001), but donor risk index [25] was compara-
ble (P=0.133). After LT, recipients of the drainage-group showed 
twice as long ICU stays (14 days versus 7 days P < 0.001) and 
longer total hospital stays (38 days versus 29 days P<0.001).
Using univariable logistic regression the following risk fac-
tors were found significant for CD placement: retransplanta-
tion, recipient BMI, laboratory MELD, INR, creatinine (md/dL), 
total bilirubin (mg/dL), urea (mg/dL), hospitalization status 
before LT (home, hospital, ICU), need for hemodialysis, cate-
cholamine therapy, ventilation, surgery duration, transfusions 
of red blood cells and fresh frozen plasma, BAR score, Model 












- Pediatric LT (n=65)
- Liver-lung transplantation (n=3)
- Retransplantation within rst 10 days (n=23)
Figure 1.  Flowchart of the study population. LT – liver 
transplantation.
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for End-Stage Liver Disease – Sodium (MELD-Na) [26], 5-vari-
able MELD [27], donor age and donor BMI. In the multivariable 
analysis recipient BMI (odds ratio (OR) 0.95, 95% CI 0.91–0.98, 
P=0.004), urea (OR 1.01, 95% CI 1.00–1.01, P=0.020), hospital-
ization status (OR 1.49, 95% CI 1.14–1.93, P=0.003), number 
of intraoperative red blood cell transfusions (OR 1.05, 95% CI 
1.02–1.08, P=0.003) and donor BMI (OR 0.95, 95% CI 0.92–0.99, 
P=0.029) remained significant as risk factors (Table 2). The 
Hosmer Lemeshow test showed a significance of P=0.885 for 
this model, indicating an adequate goodness-of-fit.
Localization of pleural effusion requiring drainage was con-
siderably unequal. Of all patients with pleural drainages, 350 
patients (97%) received a CD on the right-hand side, only 11 
patients (3.0%) had an isolated left-sided CD and 96 patients 
(26.6%) received bilateral drainage (Figure 2). Pleural drain-
age placement was performed at 3 different time points: pre-
transplantation, during LT, and post-transplantation. Typically, 
CD insertion was carried out after LT (n=394; 79.2%), most-
ly in the ICU as a bedside procedure (n=332; 66.8%), during 
reoperations (n=57; 11.5%) or postoperatively via computed 
Patients with pleural 
drainage (n=361)
Patients without pleural 
drainage (n=236)
p-Value
Recipient age*  52.9 (11.4)  53.5 (10.8) 0.548
Gender: male sex***  228 (63.2%)  156 (66.1%) 0.463
Recipient BMI*  26.2 (5,1)  28.0 (5.1) <0.001
High urgency patients***  36 (10.0%)  16 (6.8%) 0.176
Last recertificated laboratory MELD**  20 (12–33)  16 (11–22) <0.001
Pretransplant laboratory MELD**  20 (11–31)  16 (10–22) <0.001
matchMELD**  28 (20–36)  24 (17–29) <0.001
Dialysis before LT***  69 (19.1%)  26 (11.0%) 0.009
Mechanical ventilation before LT***  47 (13.0%)  9 (3.8%) <0.001
Catecholamines prior LT***  46 (12.7%)  6 (2.5%) <0.001
Donor age*  54.0 (16.5)  56.8 (17.0) 0.048
Donor BMI*  25.4 (3.9)  26.8 (4.8) <0.001
Living donor***  9 (2.5%)  10 (4.2%) 0.235
Donor risk index*  2.4 (0.5)  2.5 (0.6) 0.133
BAR*  9.7 (6.2)  7.3 (5.0) <0.001
D-MELD*  1157 (668)  997 (583) 0.002
Cold ischemia time (min)*  552.2 (176.6)  556.8 (193.5) 0.764
Split graft***  9 (2.5%)  10 (4.2%) 0.573
Surgery duration (min)*  366.0 (111.6)  339.6 (80.5) 0.001
Multi-organ LT***  14 (3.9%)  2 (0.8%) 0.025
PRBCs (units)**  8 (5–13)  6 (3–8) <0.001
FFP (units)**  24 (16–33)  20 (15–27) <0.001
ICU stay after LT (days)**  14 (7–39)  7 (5–13) <0.001
Hospital stay after LT (days)**  38 (24–68)  29 (21–45) <0.001
Table 1. Patient, donor and perioperative characteristics by necessity of pleural drainage (n=597).
* Mean+standard deviation; ** median+interquartile range; *** count (percentage). BAR – balance of risk; BMI – body mass 
index; FFP – fresh frozen plasma; ICU – Intensiv Care Unit; LT – liver transplantation; MELD – Model for End-Stage Liver Disease; 
PRBCs – packed red blood cells.
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Recipient BMI 0.93 0.90–0.96 <0.001 0.95 0.91–0.98 0.004
Waiting time 0.304
Retransplantation 2.59 1.34–5.02 0.005 0.575
matchMELD 1.04 1.02–1.05 <0.001 0.797
Last laboratory values before LT
Laboratory MELD 1.04 1.02–1.06 <0.001 0.691
INR 0.368
Serum creatinine (mg/dl) 1.28 1.08–1.52 0.004 0.717
Total bilirubin (mg/dl) 1.04 1.02–1.06 <0.001 0.985
Serum urea (mg/dl) 1.01 1.01–1.02 <0.001 1.01 1.00–1.01 0.020
Aspartate transaminase (U/l) 0.073
Alanine transaminase (U/l) 0.996
Gamma-Glutamyl-tramsferase (U/l) 0.286
Albumin (g/dl) 0.202
Serum sodium (mmol/l) 0.750
Urgency status 0.179
Hospitalization status 1.85 1.46–2.33 <0.001 1.49 1.14–1.93 0.003
Dialysis 1.90 1.17–3.08 0.009 0.081
Catecholamine therapy 5.62 2.36–13.37 <0.001 0.081
Ventilation 3.79 1.82–7.89 <0.001 0.998
Split graft 0.574
Cold ischemic time (min) 0.764
Surgery duration (min) 1.003 1.00–1.01 0.002 0.253
Multi-organ LT 4.72 1.06–20.96 0.041 0.139
PRBCs (units) 1.07 1.04–1.10 <0.001 1.05 1.02–1.08 0.003
FFPs (units) 1.03 1.01–1.04 <0.001 0.402
BAR Score 1.08 1.04–1.11 <0.001 0.817
MELD-Na 1.04 1.02–1.06 <0.001 0.589
Five-variable MELD 1.04 1.03–1.06 <0.001 0.653
Donor age 0.99 0.98–1.0 0.049 0.807
Donor BMI 0.93 0.89–0.97 <0.001 0.95 0.92–0.99 0.029
Donor Sex 0.66 0.48–0.92 0.014 0.341
Regional allocation 0.402
Donor risk index 0.138
Table 2. Risk factors associated with necessity of chest drain placement in logistic regression.
BAR – balance of risk; BMI – body mass index; FFP – fresh frozen plasma; INR – International Normalized Ratio; LT – liver 
transplantation; MELD – Model for End-Stage Liver Disease; PRBCs – packed red blood cells.
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tomography guided punctures (n=5; 1.0%). The median time-
period for CD insertion after LT was 3 days with an interquar-
tile range of 2 to 5 days. CD placement before (n=33; 6.6%) 
or during LT (n=70; 14.1%) was performed less frequently. 
Except for the small group of patients receiving CD placement 
before LT, patients did not show relevant pleural effusions in 
pre-LT chest x-rays. In accordance with Imai et al., an isolat-
ed blunting of the costophrenic angle was not classified as 
a relevant pleural effusion for the purpose of this study [28]. 
Mean drainage volume for CD placed during LT was 774.2 
mL in the first 24 hours and 1923.3 mL in the first 5 days. 
Overall CDs placed after LT drained an average of 848.5 mL 
of pleural fluid in the first 24 hours and those placed after 
LT in ICU drained mean pleural fluid volumes of 892.4 mL in 
the first 24 hours.
If the intervention was performed in the ICU, 112 patients 
(35.4%) received pre-interventional optimization of coagula-
tion. Most patients (63 patients; 56.3%) received fresh frozen 
plasma, 30 patients (26.8%) thrombocytes and 19 patients 
(17.0%) received both. In average, patients received 2 units of 
the applied blood products (fresh frozen plasma: 2 (IQR 2–3); 
platelets: 2 (IQR 1–2)). Two different types of CD were used 
predominantly, the puncture set “Pleuracan©” (n=124; 24.9%) 
or surgical suction drainage (Bülau drain, n=315; 63.4%). The 








Figure 2.  Patients receiving pleural drainage before, during or in the first ten days after liver transplantation and the localization 
thereof (study group n=597; patients with pleural drainage n=361).
Setting
Total placements (n=459) During LT (n=70) In ICU (n=332) During Re-OP (n=57)
Total complications  21 (4.6%)  0  20 (6.0%)  1 (1.8%)
Pneumothorax  6 (1.3%)  0  6 (1.8%)  0
Hemorrhage  15 (3.3%)  0  14 (4.2%)  1 (1.8%)
No complications  438 (95.4%)  70 (100%)  312 (94.0%)  56 (98.0%)
Technique
Bülau drain (n=297) Pleuracan© (n=109) Cook Medical© (n=27) Single puncture (n=26)
Total complications  13 (4.4%)  5 (4.6%)  2 (7.4%)  1 (3.8%)
Pneumothorax  5 (1.7%)  0  0  1 (3.8%)
Hemorrhage  8 (2.7%)  5 (4.6%)  2 (7.4%)  0
No complications  284 (95.6%)  104 (95.4%)  25 (96.2%)  25 (96.2%)
Table 3. Complications after pleural drainage during or after liver transplantation by setting and used technique.
ICU – Intensive Care Unit; LT – liver transplantation.
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and thoracentesis without tube insertion was only performed 
in 26 procedures (5.2%). Regarding complications, no differ-
ences (P=0.927) were observed comparing the 2 predominant 
techniques (Table 3).
CD placement-related complications included pneumothorax 
and hemorrhage (Table 3). Six patients developed pneumotho-
rax requiring further medical treatment, all 6 cases occurring 
after CD insertion in the ICU. There were 13 of 14 post-inter-
ventional bleedings that occurred in the ICU, whereas only 1 
LT recipient suffered from hemorrhage during a reoperation. 
In 2 patients, surgical removal of the hematoma was neces-
sary. No CD-related complications were developed after place-
ment during LT. Correspondingly, complication rates after place-
ment of CD were significantly higher in the ICU compared to 
LT or compared to all intraoperative procedures (P=0.035 and 
P=0.016 respectively).
Assuming a concept of pre-emptive right-sided CD inserted 
during LT in all patients, a number needed to treat (NNT) anal-
ysis revealed an NNT of 28 to prevent 1 complication of post-
operative CD placement. In high-risk patients with a labora-
tory MELD of >25 prior to LT the NNT was 12.
When analyzing the pneumonia rate in our cohort we found that 
out of 597 patients, 75 patients (12.6%) developed pneumonia 
during the first 10 days after LT. No significant differences be-
tween patients with and without CD were noted (13.9% versus 
10.6%; P=0.240). Despite representing sicker patients and a high-
er complication risk, patients with CD placement did not show 
inferior survival after LT (P=0.463 for 3-month patient survival).
Discussion
We determined that a considerable proportion of LT recipients 
suffer a pleural effusion requiring drainage in the early post-
operative phase. Among the 597 patients in our cohort, near-
ly two-thirds underwent chest tube placement within the first 
10 days after surgery, presumably due to local irritations con-
sidering that 97% of patients received a CD to the right hemi-
thorax. Critically ill patients with a higher laboratory MELD 
and those dependent on hemodialysis, mechanical ventila-
tion, or catecholamine therapy prior to LT were especially af-
fected. Furthermore, a significant correlation between proce-
dure-related parameters such as duration of surgery and the 
necessity of blood product administration was found. More 
than two-thirds of CD placements were performed bedside in 
the ICU, but intervention in the operation room was shown to 
be safer with regards to procedural complications. Moreover, 
ICU patients frequently received coagulation products prior to 
intervention, while patients undergoing surgery had no need 
for additional coagulation products.
In the existing literature, reported incidences for post-LT pleural 
effusion vary notably from 18.4% to 96.5% [5,29], but are most-
ly described as between 35% and 70% [6–8,30,31]. Among all 
analyzed patients between 9.1% and 32.4% required a pleural 
drainage, which corresponds to 18% to 52% of patients with 
pleural effusion [5–8,31]. In our cohort, we found a significant-
ly higher incidence of drainage-relevant effusions. This is most 
likely because the patients in our cohort were sicker, as reflect-
ed by higher MELD scores [30,32,33]. In the German liver trans-
plant allocation system, the MELD score is differentiated be-
tween a calculated laboratory MELD score and a match MELD 
score with exceptions for patients whose disease severity is 
not adequately reflected by the laboratory MELD score. Other 
allocation systems, used in the cited studies, only state the fi-
nal allocation MELD. The considerable difference between lab-
oratory MELD score and match MELD score in our study group 
can be best explained by the fact that 34.2% of all patients 
received allocation via MELD score exception. MELD score it-
self has been shown to be a risk factor for the development 
of pulmonary complications after LT [4,6,30,32]. Possible oth-
er risk factors contributing to the high incidence of pleural ef-
fusions found in our study cohort include the relatively high 
incidences of pre-transplant mechanical ventilation or renal 
insufficiency and high numbers of intraoperative blood trans-
fusions [6,7,33,34]. In conclusion, the high incidence of vari-
ous risk factors for pulmonary complications after LT could ex-
plain the high incidence of chest drainages seen in this study.
The increased MELD score in our cohort compared to other stud-
ies represents the increasing gap between required and avail-
able organs in Germany [35]. This inevitably results in higher 
MELD scores prior to LT [36], which is known to lead to inferior 
patient as well as graft survival, a prolonged ICU and hospital 
stay, higher intensive care unit costs [37], more administered 
blood products [38], delayed extubation [39] and – as dem-
onstrated here – increased pleural effusion rate. However, in 
times of organ scarcity, these MELD-related effects gain more 
importance in other countries as well. Currently, MELD-based 
liver allocation has become widely accepted as the basis for 
organ allocation and increasing MELD scores at the point of LT 
have been reported in other countries [40]. The incidence of 
pleural effusion after LT can only be expected to increase with 
rising MELD scores and the management of pulmonary compli-
cations after liver transplantations shall gain increasing focus.
In general, the high incidence of drainage-relevant pleural ef-
fusions may be explained by various factors in liver transplant 
recipients: 1) low serum albumin levels and postoperative hy-
poproteinemia [4]; 2) high rates of intraoperative blood and 
fluid transfusions are associated with postoperative pulmonary 
complications and early postoperative pneumonia [6,7,32,41]; 
3) local mechanisms at the right side of the diaphragm proba-
bly play an additional role. Diaphragmatic defects are a known 
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cause of hydrothorax [42] and right hemidiaphragmatic pa-
ralysis caused by right phrenic nerve injury during LT is a rec-
ognized cause of right lower lobe atelectasis [43]. Despite the 
high incidence, little is known regarding possible complications 
in this unique patient group. Given the critical state of these 
patients, it seems fundamental to optimize the treatment of 
this common complication to reduce morbidity. We were able 
to identify several risk factors for CD placement, including in-
traoperative red blood cell transfusion, pre-transplant hospi-
talization status, recipient and donor BMI and serum urea. 
These statistical risk factors certainly require critical evalua-
tion. Recipient and donor BMI are highly selected before LT 
and therefore difficult to interpret: While severe obesity may 
represent a relative contraindication for receiving LT [44,45], 
sarcopenia and frailty – as known risk factors for post-trans-
plant outcomes – are likely to be more pronounced in recipi-
ents with a low BMI [46,47]. Likewise, organs of obese donors 
are probably less used for LT due to concomitant steatosis [48]. 
Nevertheless, the number of intraoperative blood transfusions 
and the recipient’s overall health status, reflected by their hos-
pitalization status before LT, appear to be suitable and easily 
applicable risk factors for the necessity of CD. Together with 
other described risk factors for pleural effusion after LT such 
as a higher preoperative MELD score [6], these could be used 
to select patients who would benefit from preemptive inter-
vention, e.g., intraoperative CD during LT.
Further subgroup analysis was performed for drainage type 
(placement via needle puncture or surgical approach) and the 
circumstances of the application (operation room or the ICU). 
Decisions for indication, drainage type, and time point of the 
intervention were made by the responsible clinician. Whereas 
the type of drainage inserted did not alter significant rele-
vance, the setting of CD procedure played a major role. The 
majority of CDs were performed post-LT bedside in the ICU 
under ultrasound guidance; others were placed directly dur-
ing LT or in the context of reoperations. The rates of pneumo-
thorax as well as of hemothorax after intraoperative CD place-
ments were significantly lower compared to the interventions 
in the ICU. Furthermore, no additional optimization of coagu-
lation was necessary as coagulation had been routinely opti-
mized during major surgery. Although the necessity for coag-
ulation products prior to minor interventions such as pleural 
drainage [18] is controversial, reducing the risk of bleeding 
by transfusion of fresh frozen plasma and platelets was per-
formed in more than one-third of all drainage insertions in 
the ICU. However, blood product transfusion itself can cause 
side-effects, e.g., transfusion-related acute lung injury, acute 
and delayed transfusion reactions or at least unnecessary im-
munological sensitization [49–51]. In addition, blood products 
also represent an economic burden for hospitals and health 
systems [52]. Hence, intraoperative CD insertion represents 
an opportunity to reduce the total amount of administered 
blood and coagulation products. Different aspects likely con-
tribute to our finding of safer placement in the OR compared 
to ICU. The overall setting is more controlled in the OR (e.g., 
patient position and equipment), and experience of the exe-
cuting clinician may also vary between OR and ICU: placement 
during LT has the advantage of the attendance of a highly ex-
perienced surgeon. The prevention of potential complications 
and the reduction of blood transfusions could be benefits of 
preemptive placement of CD drains during surgery, especial-
ly in liver recipients with high risk for development of pulmo-
nary complications.
In addition to better oxygenation, pneumonia prophylaxis rep-
resents an important indication for the drainage of pleural ef-
fusions as most cases of bacterial pneumonia after LT occur on 
the base of pleural effusion or atelectasis [31]. Interestingly, 
in our study no differences in pneumonia rates between the 
drainage group and the no-drainage group were identified. 
This might be interpreted as a positive result, because the 
group with need for a CD presented more pulmonary risk fac-
tors. Therefore, one would have expected this group to devel-
op pneumonia more frequently, which did not occur.
Although CD placement can be referred to as a standard pro-
cedure, our findings show that there remains room for im-
provement in morbidity regarding pleura effusion-related 
complications, especially in a cohort of critically ill liver trans-
plant recipients.
The concept of pre-emptive placement of right-sided CD in ev-
ery patient immediately post-LT is not entirely new and was 
recommended by Lin et al. in 2010 [6]. Since then, the concept 
has seen little attention and at the time of publication there 
was only 1 existing study on a preemptive approach for CD 
insertion before LT: in a living donor LT cohort in Japan; Imai 
et al. analyzed risk factors for postoperative atelectasis and 
accordingly performed preoperative thoracic drainage if risk 
factors were present. They demonstrated that the group with 
preemptive thoracic drainage for at-risk patients showed sig-
nificantly less atelectasis after LT, contracted pneumonia at a 
lower incidence and had a shorter ICU stay [28]. Despite ma-
jor differences in LT between Japan and Germany (e.g., per-
centage of living donor transplantations [53]) these findings 
support the concept of preemptive CD to reduce morbidity.
Our study had some limitations. Firstly, data generation was 
conducted retrospectively in a single LT center. Due to its ob-
servational design, there was no rigid study protocol for the 
indication for CD insertion. Indications and procedure of CD 
placement may vary between different medical systems, trans-
plantation centers and between clinicians, which decreases the 
generalizability of our findings.
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Conclusions
In conclusion, pleura effusion is one of the most common com-
plications after LT and a majority of patients require interven-
tional treatment. CD placement in LT recipients was associat-
ed with fewer complications if performed in the OR during LT 
or reoperations compared to placement on ICU. Further pro-
spective studies should evaluate preemptive CD placement 
during LT, especially in high-risk patients.
Acknowledgment
We acknowledge support from the Open Access Publication 




 1. Adam R, Karam V, Delvart V et al: Evolution of indications and results of liv-
er transplantation in Europe. A report from the European Liver Transplant 
Registry (ELTR). J Hepatol, 2012; 57(3): 675–88
 2. Busuttil RW, Lake JR: Role of tacrolimus in the evolution of liver transplan-
tation. Transplantation, 2004; 77(9 Suppl.): S44–51
 3. McElroy LM, Daud A, Davis AE et al: A meta-analysis of complications fol-
lowing deceased donor liver transplant. Am J Surg, 2014; 208(4): 605–18
 4. Feltracco P, Carollo C, Barbieri S et al: Early respiratory complications after 
liver transplantation. World J Gastroenterol, 2013; 19(48): 9271–81
 5. Bozbas SS, Eyuboglu FO, Ozturk Ergur F et al: Pulmonary complications and 
mortality after liver transplant. Exp Clin Transplant, 2008; 6(4): 264–70
 6. Lin YH, Cai ZS, Jiang Y et al: Perioperative risk factors for pulmonary com-
plications after liver transplantation. J Int Med Res, 2010; 38(5): 1845–55
 7. Pirat A, Ozgur S, Torgay A et al: Risk factors for postoperative respiratory 
complications in adult liver transplant recipients. Transplant Proc, 2004; 
36(1): 218–20
 8. Hong SK, Hwang S, Lee SG et al: Pulmonary complications following adult 
liver transplantation. Transplant Proc, 2006; 38(9): 2979–81
 9. Razazi K, Thille AW, Carteaux G et al: Effects of pleural effusion drainage 
on oxygenation, respiratory mechanics, and hemodynamics in mechanical-
ly ventilated patients. Ann Am Thorac Soc, 2014; 11(7): 1018–24
 10. Brims FJ, Davies MG, Elia A, Griffiths MJ: The effects of pleural fluid drain-
age on respiratory function in mechanically ventilated patients after car-
diac surgery. BMJ Open Respir Res, 2015; 2(1): e000080
 11. van Kaam AH, Lachmann RA, Herting E et al: Reducing atelectasis attenu-
ates bacterial growth and translocation in experimental pneumonia. Am J 
Respir Crit Care Med, 2004; 169(9): 1046–53
 12. Squadrone V, Coha M, Cerutti E et al: Continuous positive airway pressure 
for treatment of postoperative hypoxemia: A randomized controlled trial. 
JAMA, 2005; 293(5): 589–95
 13. Cantey EP, Walter JM, Corbridge T, Barsuk JH: Complications of thoracen-
tesis: Incidence, risk factors, and strategies for prevention. Curr Opin Pulm 
Med, 2016; 22(4): 378–85
 14. Mercaldi CJ, Lanes SF: Ultrasound guidance decreases complications and 
improves the cost of care among patients undergoing thoracentesis and 
paracentesis. Chest, 2013; 143(2): 532–38
 15. Zhan C, Smith M, Stryer D: Accidental iatrogenic pneumothorax in hospi-
talized patients. Med Care, 2006; 44(2): 182–86
 16. Castellote J, Xiol X, Cortes-Beut R et al: Complications of thoracentesis in 
cirrhotic patients with pleural effusion. Rev Esp Enferm Dig, 2001; 93(9): 
566–75
 17. Havelock T, Teoh R, Laws D, Gleeson F, BTS Pleural Disease Guideline Group: 
Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural 
Disease Guideline 2010. Thorax, 2010; 65(Suppl. 2): ii61–76
 18. Puchalski JT, Argento AC, Murphy TE et al: The safety of thoracentesis in 
patients with uncorrected bleeding risk. Ann Am Thorac Soc, 2013; 10(4): 
336–41
 19. Villena Garrido V, Cases Viedma E, Fernandez Villar A et al: Recommendations 
of diagnosis and treatment of pleural effusion. Update. Arch Bronconeumol, 
2014; 50(6): 235–49
 20. Feller-Kopman DJ, Reddy CB, DeCamp MM et al: Management of malignant 
pleural effusions. An official ATS/STS/STR clinical practice guideline. Am J 
Respir Crit Care Med, 2018; 198(7): 839–49
 21. Mandell LA, Wunderink RG, Anzueto A et al: Infectious Diseases Society of 
America/American Thoracic Society consensus guidelines on the manage-
ment of community-acquired pneumonia in adults. Clin Infect Dis, 2007; 
44(Suppl. 2): S27–72
 22. Wiesner R, Edwards E, Freeman R et al: Model for end-stage liver disease 
(MELD) and allocation of donor livers. Gastroenterology, 2003; 124(1): 91–96
 23. Dutkowski P, Oberkofler CE, Slankamenac K et al: Are there better guide-
lines for allocation in liver transplantation? A novel score targeting justice 
and utility in the model for end-stage liver disease era. Ann Surg, 2011; 
254(5): 745–53; discussion 753
 24. Halldorson JB, Bakthavatsalam R, Fix O et al: D-MELD, a simple predictor of 
post liver transplant mortality for optimization of donor/recipient match-
ing. Am J Transplant, 2009; 9(2): 318–26
 25. Feng S, Goodrich NP, Bragg-Gresham JL et al: Characteristics associated 
with liver graft failure: The concept of a donor risk index. Am J Transplant, 
2006; 6(4): 783–90
 26. Kim WR, Biggins SW, Kremers WK et al: Hyponatremia and mortality among 
patients on the liver-transplant waiting list. N Engl J Med, 2008; 359(10): 
1018–26
 27. Myers RP, Shaheen AA, Faris P et al: Revision of MELD to include serum al-
bumin improves prediction of mortality on the liver transplant waiting list. 
PLoS One, 2013; 8(1): e51926
 28. Imai D, Ikegami T, Toshima T et al: Preemptive thoracic drainage to eradi-
cate postoperative pulmonary complications after living donor liver trans-
plantation. J Am Coll Surg, 2014; 219(6): 1134–42e2
 29. Panfili E, Nicolini D, Polverini V et al: Importance of radiological detection 
of early pulmonary acute complications of liver transplantation: Analysis 
of 259 cases. Radiol Med, 2015; 120(5): 413–20
 30. Aydin C, Otan E, Akbulut S et al: Postoperative pulmonary complications af-
ter liver transplantation: Assessment of risk factors for mortality. Transplant 
Proc, 2015; 47(5): 1488–94
 31. Golfieri R, Giampalma E, Morselli Labate AM et al: Pulmonary complications 
of liver transplantation: Radiological appearance and statistical evaluation 
of risk factors in 300 cases. Eur Radiol, 2000; 10(7): 1169–83
 32. Levesque E, Hoti E, Azoulay D et al: Pulmonary complications after elective 
liver transplantation-incidence, risk factors, and outcome. Transplantation, 
2012; 94(5): 532–38
 33. Li X, Chen C, Wei X et al: Retrospective comparative study on postoperative 
pulmonary complications after orthotopic liver transplantation using the 
Melbourne group Scale (MGS-2) diagnostic criteria. Ann Transplant, 2018; 
23: 377–86
 34. Huang CT, Lin HC, Chang SC, Lee WC: Pre-operative risk factors predict post-
operative respiratory failure after liver transplantation. PLoS One, 2011; 
6(8): e22689
 35. Branger P, Samuel U: Annual report. Den Haag: Eurotransplant International 
Foundation, 2016
 36. Blok JJ, Braat AE, Adam R et al: Validation of the donor risk index in ortho-
topic liver transplantation within the Eurotransplant region. Liver Transpl, 
2012; 18(1): 112–19
 37. Foxton MR, Al-Freah MA, Portal AJ et al: Increased model for end-stage liv-
er disease score at the time of liver transplant results in prolonged hospi-
talization and overall intensive care unit costs. Liver Transpl, 2010; 16(5): 
668–77
 38. Schlegel A, Linecker M, Kron P et al: Risk assessment in high- and low-MELD 
liver transplantation. Am J Transplant, 2017; 17(4): 1050–63
e918456-9
Wiering L. et al.: 
Perioperative pleural drainage in liver transplantation
© Ann Transplant, 2020; 25: e918456
ORIGINAL PAPER
Indexed in: [Science Citation Index Expanded] [Index Medicus/MEDLINE] 
[Chemical Abstracts] [Scopus]
This work is licensed under Creative Common Attribution-
NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
 39. Biancofiore G, Bindi ML, Romanelli AM et al: Fast track in liver transplan-
tation: 5 years’ experience. Eur J Anaesthesiol, 2005; 22(8): 584–90
 40. Fayek SA, Quintini C, Chavin KD, Marsh CL: The current state of liver trans-
plantation in the united states: perspective from American society of trans-
plant surgeons (ASTS) scientific studies committee and endorsed by ASTS 
council. Am J Transplant, 2016; 16(11): 3093–104
 41. Jiang GQ, Peng MH, Yang DH: Effect of perioperative fluid therapy on ear-
ly phase prognosis after liver transplantation. Hepatobiliary Pancreat Dis 
Int, 2008; 7(4): 367–72
 42. Chen A, Ho YS, Tu YC et al: Diaphragmatic defect as a cause of massive hy-
drothorax in cirrhosis of liver. J Clin Gastroenterol, 1988; 10(6): 663–66
 43. McAlister VC, Grant DR, Roy A et al: Right phrenic nerve injury in orthotop-
ic liver transplantation. Transplantation, 1993; 55(4): 826–30
 44. Farkas S, Hackl C, Schlitt HJ: Overview of the indications and contraindica-
tions for liver transplantation. Cold Spring Harb Perspect Med, 2014; 4(5): 
pii: a015602
 45. Varma V, Mehta N, Kumaran V, Nundy S: Indications and contraindications 
for liver transplantation. Int J Hepatol, 2011; 2011: 121862
 46. Englesbe MJ, Patel SP, He K et al: Sarcopenia and mortality after liver trans-
plantation. J Am Coll Surg, 2010; 211(2): 271–78
 47. Kaido T, Ogawa K, Fujimoto Y et al: Impact of sarcopenia on survival in pa-
tients undergoing living donor liver transplantation. Am J Transplant, 2013; 
13(6): 1549–56
 48. Perito ER, Rhee S, Glidden D et al: Impact of the donor body mass index 
on the survival of pediatric liver transplant recipients and post-transplant 
obesity. Liver Transpl, 2012; 18(8): 930–39
 49. Redfield RR, Scalea JR, Zens TJ et al: The mode of sensitization and its in-
fluence on allograft outcomes in highly sensitized kidney transplant recip-
ients. Nephrol Dial Transplant, 2016; 31(10): 1746–53
 50. Zimring JC, Stowell SR, Johnsen JM, Hendrickson JE: Effects of genetic, epi-
genetic, and environmental factors on alloimmunization to transfused an-
tigens: Current paradigms and future considerations. Transfus Clin Biol, 
2012; 19(3): 125–31
 51. Baron RM: Point: Should coagulopathy be repaired prior to central venous 
line insertion? Yes: Why take chances? Chest, 2012; 141(5): 1139–42
 52. Toner RW, Pizzi L, Leas B et al: Costs to hospitals of acquiring and process-
ing blood in the US: A survey of hospital-based blood banks and transfu-
sion services. Appl Health Econ Health Policy, 2011; 9(1): 29–37
 53. Egawa H, Tanabe K, Fukushima N et al: Current status of organ transplan-
tation in Japan. Am J Transplant, 2012; 12(3): 523–30
e918456-10
Wiering L. et al.: 
Perioperative pleural drainage in liver transplantation
© Ann Transplant, 2020; 25: e918456
ORIGINAL PAPER
Indexed in: [Science Citation Index Expanded] [Index Medicus/MEDLINE] 
[Chemical Abstracts] [Scopus]
This work is licensed under Creative Common Attribution-
NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
